These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 34191080

  • 1. Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    Mohamed AZ, Nestor PJ, Cumming P, Nasrallah FA, Alzheimer’s Disease Neuroimaging Initiative.
    J Neurol; 2022 Feb; 269(2):873-884. PubMed ID: 34191080
    [Abstract] [Full Text] [Related]

  • 2. Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury.
    Mohamed AZ, Cumming P, Srour H, Gunasena T, Uchida A, Haller CN, Nasrallah F, Department of Defense Alzheimer's Disease Neuroimaging Initiative.
    Neuroimage Clin; 2018 Feb; 19():716-726. PubMed ID: 30009128
    [Abstract] [Full Text] [Related]

  • 3. Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS).
    Cummins TL, Doré V, Feizpour A, Krishnadas N, Bourgeat P, Elias A, Lamb F, Williams R, Hopwood M, Landau S, Villemagne VL, Weiner M, Rowe CC.
    J Neurotrauma; 2023 Jun; 40(11-12):1086-1097. PubMed ID: 36855333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW, Chau ACM, Chiu PK, Shea YF, Kwan JSK, Chan FHW, Mak HK.
    J Alzheimers Dis; 2021 Jun; 79(2):819-832. PubMed ID: 33361593
    [Abstract] [Full Text] [Related]

  • 10. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY, Zhang YR, Guo Y, Du J, Ren P, Wu BS, Feng JF, Alzheimer's Disease Neuroimaging Initiative, Cheng W, Yu JT.
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [Abstract] [Full Text] [Related]

  • 11. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA.
    Neuroimage; 2017 Mar 01; 148():296-304. PubMed ID: 27989773
    [Abstract] [Full Text] [Related]

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ, Devous MD, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA, 18F-AV-1451-A05 investigators.
    Brain; 2017 Mar 01; 140(3):748-763. PubMed ID: 28077397
    [Abstract] [Full Text] [Related]

  • 13. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM, Hwang J, Lee JM, Roh JH, Lee JH, Koh JY, Alzheimer’s Disease Neuroimaging Initiative (ADNI).
    Curr Alzheimer Res; 2015 Mar 01; 12(6):563-71. PubMed ID: 26027813
    [Abstract] [Full Text] [Related]

  • 14. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJ, AV45-A11 Study Group.
    Neurology; 2012 Oct 16; 79(16):1636-44. PubMed ID: 22786606
    [Abstract] [Full Text] [Related]

  • 15. Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease.
    Teng E, Manser PT, Sanabria Bohorquez S, Wildsmith KR, Pickthorn K, Baker SL, Ward M, Kerchner GA, Weimer RM.
    Alzheimers Res Ther; 2021 Dec 01; 13(1):196. PubMed ID: 34852837
    [Abstract] [Full Text] [Related]

  • 16. Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers.
    Weiner MW, Harvey D, Landau SM, Veitch DP, Neylan TC, Grafman JH, Aisen PS, Petersen RC, Jack CR, Tosun D, Shaw LM, Trojanowski JQ, Saykin AJ, Hayes J, De Carli C, Alzheimer's Disease Neuroimaging Initiative and the Department of Defense Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement; 2023 Mar 01; 19(3):884-895. PubMed ID: 35768339
    [Abstract] [Full Text] [Related]

  • 17. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y.
    Int J Geriatr Psychiatry; 2015 May 01; 30(5):505-13. PubMed ID: 25043833
    [Abstract] [Full Text] [Related]

  • 18. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
    Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging Initiative.
    Brain; 2009 May 01; 132(Pt 5):1355-65. PubMed ID: 19339253
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
    Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM.
    JAMA Neurol; 2016 Sep 01; 73(9):1070-7. PubMed ID: 27454922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.